Research suggests that targeting a specific pathway, PSMD14-BCKDK, may help overcome immune suppression and improve treatment outcomes in glioblastoma. However, the role of related pathways and mechanisms in cancer treatment is still being explored, with some studies investigating their potential in other types of cancer, such as triple negative breast cancer. The relationship between these pathways and cancer treatment is complex and appears to involve multiple factors and mechanisms.